Literature DB >> 16674175

Label-free measurement of microbicidal gel thickness using low-coherence interferometry.

Kelly E Braun, Jeffrey D Boyer, Marcus H Henderson, David F Katz, Adam Wax.   

Abstract

Spectral-domain low-coherence interferometry (LCI) was used to measure the thickness of microbicidal gels applied to a cylindrical calibration test socket. Microbicides are topical formulations containing active ingredients targeted to inhibit specific pathogens that are currently under development for application to the epithelial lining of the lower female reproductive tract to combat sexually transmitted infections such as HIV. Understanding the deployment and drug delivery of these formulations is vital to maximizing their effectiveness. Previously, in vivo measurements of microbicidal formulation thickness were assessed using fluorescence measurements of fluorescein-labeled gels via an optical endoscope-based device. Here we present an LCI-based device that measures the thickness of a formulation without the use of any exogenous agents by analyzing the interference pattern generated between the reflections from the front and back surface of the sample. Results are presented that validate the effectiveness and performance of the LCI measurement in a clinically relevant system as compared to an existing fluorescence-based method. The impact of the new LCI-based design on in vivo measurements is discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16674175     DOI: 10.1117/1.2192767

Source DB:  PubMed          Journal:  J Biomed Opt        ISSN: 1083-3668            Impact factor:   3.170


  2 in total

Review 1.  Clinical evaluation of microbicide formulations.

Authors:  Kathleen M Morrow; Craig Hendrix
Journal:  Antiviral Res       Date:  2010-12       Impact factor: 5.970

2.  Design and validation of a multiplexed low coherence interferometry instrument for in vivo clinical measurement of microbicide gel thickness distribution.

Authors:  Tyler K Drake; Michael G Desoto; Jennifer J Peters; Marcus H Henderson; Amy P Murtha; David F Katz; Adam Wax
Journal:  Biomed Opt Express       Date:  2011-09-26       Impact factor: 3.732

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.